S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(0.23%) $78.29
Gas
(0.84%) $2.16
Gold
(-0.26%) $2 302.70
Silver
(0.08%) $26.71
Platinum
(-0.54%) $960.10
USD/EUR
(0.07%) $0.929
USD/NOK
(-0.08%) $10.87
USD/GBP
(0.02%) $0.797
USD/RUB
(0.00%) $91.45

实时更新: Suzuken Co., Ltd. [9987.T]

交易所: JPX 部门: Healthcare 工业: Medical Distribution
最后更新时间2 May 2024 @ 14:15

1.75% ¥ 4 821.00

Live Chart Being Loaded With Signals

Commentary (2 May 2024 @ 14:15):

Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the wholesale of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution Business, Pharmaceutical Manufacturing Business, Pharmacy Business, and Healthcare-Related Services Business...

Stats
今日成交量 308 700
平均成交量 291 216
市值 300.54B
EPS ¥0 ( 2024-02-08 )
下一个收益日期 ( ¥83.23 ) 2024-05-13
Last Dividend ¥36.00 ( 2023-03-30 )
Next Dividend ¥0 ( N/A )
P/E 14.25
ATR14 ¥2.70 (0.06%)

音量 相关性

長: -0.23 (neutral)
短: 0.76 (moderate)
Signal:(61.659) Neutral

Suzuken Co., Ltd. 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Suzuken Co., Ltd. 相关性 - 货币/商品

The country flag -0.58
( weak negative )
The country flag -0.10
( neutral )
The country flag -0.39
( neutral )
The country flag -0.08
( neutral )
The country flag -0.61
( weak negative )

Suzuken Co., Ltd. 财务报表

Annual 2022
营收: ¥2 314.83B
毛利润: ¥179.70B (7.76 %)
EPS: ¥236.46
FY 2022
营收: ¥2 314.83B
毛利润: ¥179.70B (7.76 %)
EPS: ¥236.46
FY 2022
营收: ¥2 232.77B
毛利润: ¥160.99B (7.21 %)
EPS: ¥163.19
FY 2021
营收: ¥2 128.48B
毛利润: ¥157.84B (7.42 %)
EPS: ¥88.52

Financial Reports:

No articles found.

Suzuken Co., Ltd. Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
¥36.00
(N/A)
¥0
(N/A)
¥36.00
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)

Suzuken Co., Ltd. Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 6.61 - average (87.08%) | Divividend Growth Potential Score: 2.58 - Decrease likely (48.49%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend ¥9.09 2001-03-27
Last Dividend ¥36.00 2023-03-30
Next Dividend ¥0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 46 --
Total Paid Out ¥939.27 --
Avg. Dividend % Per Year 0.00% --
Score 2.84 --
Div. Sustainability Score 6.61
Div.Growth Potential Score 2.58
Div. Directional Score 4.59 --
Next Divdend (Est)
(2024-07-03)
¥0 Estimate 1.26 %
Dividend Stability
0.10 Bad
Dividend Score
2.84
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for JPX

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
8563.T Ex Dividend Junior 2024-03-28 Annually 0 0.00%
7893.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
7037.T Ex Dividend Junior 2023-12-28 Annually 0 0.00%
6368.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
5269.T Ex Dividend Junior 2023-09-28 Semi-Annually 0 0.00%
4343.T Ex Dividend Knight 2024-02-28 Semi-Annually 0 0.00%
3501.T Ex Dividend Knight 2023-11-29 Semi-Annually 0 0.00%
2735.T Ex Dividend Junior 2023-08-30 Annually 0 0.00%
9628.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
8163.T Ex Dividend Junior 2024-03-28 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.01171.5009.7710.00[0 - 0.5]
returnOnAssetsTTM0.02121.2009.2910.00[0 - 0.3]
returnOnEquityTTM0.06641.500-0.373-0.560[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM1.1860.8009.077.26[1 - 3]
quickRatioTTM0.9540.8009.107.28[0.8 - 2.5]
cashRatioTTM0.2061.5009.9710.00[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM807.191.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM212.652.0010.0010.00[0 - 30]
freeCashFlowPerShareTTM212.652.0010.0010.00[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM0.07751.000-2.04-2.04[0.2 - 0.8]
operatingProfitMarginTTM0.01461.000-1.707-1.707[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM1.8180.8001.2130.970[0.5 - 2]
Total Score6.61

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM14.111.0008.680[1 - 100]
returnOnEquityTTM0.06642.50-0.240-0.560[0.1 - 1.5]
freeCashFlowPerShareTTM212.652.0010.0010.00[0 - 30]
dividendYielPercentageTTM1.6591.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM212.652.0010.0010.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-3.661.500-10.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.007271.000-2.320[0.1 - 0.5]
Total Score2.58

Suzuken Co., Ltd.

Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the wholesale of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution Business, Pharmaceutical Manufacturing Business, Pharmacy Business, and Healthcare-Related Services Business. The Pharmaceutical Distribution Business segment procures ethical drugs, diagnostic reagents, medical equipment and supplies, and other health-related items from manufacturers and supplies to medical institutions and pharmacies. The Pharmaceutical Manufacturing Business segment engages in the research and development, manufacturing, and marketing of ethical pharmaceuticals and diagnostic products focusing on the areas of diabetes and kidney diseases. The Pharmacy Business segment provides services through family pharmacists, as well as improves the operations of local pharmacies and provides educational support. The Healthcare-Related Services Business segment provides manufacturer support services, such as contract distribution for manufacturers; distribution of orphan drugs; and nursing care services, as well as develops, manufactures, and sells electrocardiographs, sphygmomanometers, stethoscopes, medical materials, and health promotion equipment. Suzuken Co., Ltd. also publishes medical magazines for medical institutions. The company has collaboration with Bushu Pharmaceuticals Ltd. provide contract specialty drug services. Suzuken Co., Ltd. was founded in 1932 and is headquartered in Nagoya, Japan.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。